(lp0
S'The Way Analysts See GenVec, Inc.  Post Analyst - 23 hours ago GenVec, Inc.  traded at an unexpectedly low level on 03/27/2017 when the stock experienced a 7.68 gain to a closing price of $6.59.'
p1
aS'GenVec Inc  Is Another Low Float Runner Insider Financial - Jan 11, 2017 Low floats have been the name of the game for a number of biotech companies this week, with some seemingly inexplicable runs only explained by low float, high-volume spikes.'
p2
aS'Intrexon to acquire fellow Md. biotech Washington Business Journal - Jan 24, 2017 Germantown-based Intrexon Corp. is swallowing up its fellow Montgomery County biotech, GenVec Inc., a small Gaithersburg gene therapy company that has been struggling to grow since its lead cancer drug candidate failed in late-stage trials in 2010.GenVec Inc.  Is Up Sharply After Bought By Intrexon - RTT NewsIntrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform - PR Newswire '
p3
aS'GenVec to Present at Phacilitate Cell &amp; Gene Therapy World 2017 PR Newswire  - Jan 11, 2017 GAITHERSBURG, Md., Jan. 11, 2017 /PRNewswire/ -- GenVec, Inc. , a clinical-stage gene delivery company, announced today that its chief scientific officer, Douglas E. Brough, will present a talk entitled &quot;AdenoVerse platform for&nbsp;...'
p4
aS'6.25 MarketWatch - Dec 21, 2009 GenVec Inc. NASDAQ: GNVC. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p5
aS'GenVec Inc. GNVC  Wall Street Journal - Feb 12, 2011 News GenVec Inc.GNVC. Significant News Only. 03/09/17; Press Release. Research Reports Initiation on Biotech Stocks -- Alnylam Pharma, INSYS Therapeutics, Curis, and GenVec.'
p6
aS"Here's Who Just Picked Up Genvec Inc.  Shares Small Cap Exclusive  - Feb 17, 2017 For those not familiar with the company, GenVec, Inc.  is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines."
p7
aS'GenVec, Inc. , Interview with Doug Swirsky, CEO Nasdaq - Feb 24, 2015 GenVec is a pioneer in the design, testing and manufacture of adenovectored product candidates that can deliver on the promise of gene-based medicine.'
p8
aS'GenVec Provides Update on Hearing Loss Clinical Program PR Newswire  - May 2, 2016 GAITHERSBURG, Md., May 2, 2016 /PRNewswire/ -- GenVec, Inc. , a clinical-stage gene delivery company, announced today that it was notified by its collaborator Novartis that the Data Safety Monitoring Board  for the Phase 1/2&nbsp;...'
p9
aS'Lifshitz &amp; Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc ... PR Newswire  - Feb 17, 2017 Lifshitz &amp; Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience, Inc., Novan, Inc., Regulus Therapeutics Incs.'
p10
a.